These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24773346)

  • 1. Virtual screening for cholesterol absorption inhibitors.
    Sun L; Qian H; Huang W
    Med Chem; 2014; 11(1):2-12. PubMed ID: 24773346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on patented cholesterol absorption inhibitors.
    Chhabria MT; Mahajan BM
    Expert Opin Ther Pat; 2009 Aug; 19(8):1083-107. PubMed ID: 19552506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.
    Ge L; Wang J; Qi W; Miao HH; Cao J; Qu YX; Li BL; Song BL
    Cell Metab; 2008 Jun; 7(6):508-19. PubMed ID: 18522832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe, a selective inhibitor of the transport of cholesterol.
    Miura S; Saku K
    Intern Med; 2008; 47(13):1165-70. PubMed ID: 18591835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe and other azetidinone cholesterol absorption inhibitors.
    Clader JW
    Curr Top Med Chem; 2005; 5(3):243-56. PubMed ID: 15857308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
    Davis HR; Veltri EP
    J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption.
    Wang J; Chu BB; Ge L; Li BL; Yan Y; Song BL
    J Lipid Res; 2009 Aug; 50(8):1653-62. PubMed ID: 19325169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharaceutical chemical characterization of ezetimibe.
    Blanka SS; Gabor O; Hajnal K
    Acta Pharm Hung; 2016; 86(4):133-139. PubMed ID: 29870599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs.
    Hawes BE; O'neill KA; Yao X; Crona JH; Davis HR; Graziano MP; Altmann SW
    Mol Pharmacol; 2007 Jan; 71(1):19-29. PubMed ID: 17005902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis: cell biology and lipoproteins: cholesterol absorption inhibitors: gateway therapy for hypercholesterolaemia.
    Brown AJ
    Curr Opin Lipidol; 2002 Dec; 13(6):701-3. PubMed ID: 12441896
    [No Abstract]   [Full Text] [Related]  

  • 13. Niemann-Pick C1-Like 1 and cholesterol uptake.
    Wang LJ; Song BL
    Biochim Biophys Acta; 2012 Jul; 1821(7):964-72. PubMed ID: 22480541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells.
    Field FJ; Watt K; Mathur SN
    J Lipid Res; 2007 Aug; 48(8):1735-45. PubMed ID: 17473178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
    Jia L; Betters JL; Yu L
    Annu Rev Physiol; 2011; 73():239-59. PubMed ID: 20809793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane.
    Knöpfel M; Davies JP; Duong PT; Kvaernø L; Carreira EM; Phillips MC; Ioannou YA; Hauser H
    Biochim Biophys Acta; 2007 Sep; 1771(9):1140-7. PubMed ID: 17689140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
    Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
    Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake.
    Hu M; Yang F; Huang Y; You X; Liu D; Sun S; Sui SF
    Sci Adv; 2021 Jul; 7(29):. PubMed ID: 34272236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.